The market for Home Infusion Therapy is expected to reach USD XX million Bn in 2022.
Home infusion therapy refers to administering biological drugs in a patient’s home, either by the patient themselves, their family, nurse, or others. Home infusion services include patient training and education, administration, care coordination, pharmacy services, and others. These services and supplies are usually provided by physicians and pharmacy staff, where initially, the patient picks up medications from the physician’s office. Through agencies, nursing services for home care are also provided.
The senior population is the largest consumer of home infusion therapy. As the global population is aging, this population possesses a high risk and susceptibility of this population group to developing chronic conditions that require infusion therapy. Growing demand for home healthcare by the disabled patient group will additionally widen the base for home infusion therapy. Augmenting the use of home infusion therapy also results in a reduction in hospital readmission and in-patient stays, thus containing healthcare costs. Home infusion therapy is also instrumental in reducing the risk of contracting nosocomial infections, thus presenting a potential market penetration opportunity.
Product Category
Clinical Nutrition
Geography
Fresenius Kabi, Baxter, Inc., B. Braun Melsungen AG, Smiths Medical, CareFusion Corporation, Caesarea Medical Electronics, and several others
The market for Home Infusion Therapy is expected to reach USD XX million Bn in 2022.
The Home Infusion Therapy market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forcasted from 2014 -2022
The base year of this report is 2013.